Inflammation and Uncoupling as Mechanisms of Periodontal Bone Loss

Periodontal disease is characterized by both inflammation and bone loss. Advances in research in both these areas have led to a new appreciation of not only each field but also the intimate relationship between inflammation and bone loss. This relationship has resulted in a new field of science called osteoimmunology and provides a context for better understanding the pathogenesis of periodontal disease. In this review, we discuss several aspects of the immuno-inflammatory host response that ultimately results in loss of alveolar bone. A proposal is made that periodontal inflammation not only stimulates osteoclastogenesis but also interferes with the uncoupling of bone formation and bone resorption, consistent with a pathologic process. Furthermore, arguments based on experimental animal models suggest a critical role of the spatial and temporal aspects of inflammation in the periodontium. A review of these findings leads to a new paradigm to help explain more fully the impact of inflammation on alveolar bone in periodontal disease so that it includes the effects of inflammation on uncoupling of bone formation from resorption.

[1]  A. Schmidt,et al.  A murine model of accelerated periodontal disease in diabetes. , 2010, Journal of periodontal research.

[2]  P. Bartold,et al.  Mechanisms and control of pathologic bone loss in periodontitis. , 2010, Periodontology 2000.

[3]  Yuuki Imai,et al.  Antitumor necrotic factor agent promotes BMP-2-induced ectopic bone formation , 2010, Journal of Bone and Mineral Metabolism.

[4]  R. DePinho,et al.  FoxO1 expression in osteoblasts regulates glucose homeostasis through regulation of osteocalcin in mice. , 2010, The Journal of clinical investigation.

[5]  E. Lewiecki,et al.  Denosumab update , 2009, Current opinion in rheumatology.

[6]  D. Burr,et al.  Osteoblast Function Is Compromised at Sites of Focal Bone Erosion in Inflammatory Arthritis , 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[7]  K. Guan,et al.  Inhibition of Osteoblast Functions by IKK/NF-κB in Osteoporosis , 2009, Nature Medicine.

[8]  Yu-cai Fu,et al.  Resveratrol inhibits the expression of SREBP1 in cell model of steatosis via Sirt1-FOXO1 signaling pathway. , 2009, Biochemical and biophysical research communications.

[9]  D. Graves,et al.  Activation of the Acquired Immune Response Reduces Coupled Bone Formation in Response to a Periodontal Pathogen1 , 2008, The Journal of Immunology.

[10]  N. Sims,et al.  Bone remodeling: Multiple cellular interactions required for coupling of bone formation and resorption. , 2008, Seminars in cell & developmental biology.

[11]  J. Cirelli,et al.  AAV2/1-TNFR:Fc Gene Delivery Prevents Periodontal Disease Progression , 2008, Gene Therapy.

[12]  D. Graves Cytokines that promote periodontal tissue destruction. , 2008, Journal of periodontology.

[13]  D. Cochran Inflammation and bone loss in periodontal disease. , 2008, Journal of periodontology.

[14]  T. E. Dyke,et al.  The Management of Inflammation in Periodontal Disease , 2008 .

[15]  K. Kirkwood,et al.  A dominant function of p38 mitogen-activated protein kinase signaling in receptor activator of nuclear factor-kappaB ligand expression and osteoclastogenesis induction by Aggregatibacter actinomycetemcomitans and Escherichia coli lipopolysaccharide. , 2008, Journal of periodontal research.

[16]  G. Garlet,et al.  The essential role of IFN-gamma in the control of lethal Aggregatibacter actinomycetemcomitans infection in mice. , 2008, Microbes and infection.

[17]  H. Baker,et al.  Beyond Good and Evil in the Oral Cavity: Insights into Host-Microbe Relationships Derived from Transcriptional Profiling of Gingival Cells , 2008, Journal of dental research.

[18]  Takao Shimizu,et al.  The roles of prostanoids, leukotrienes, and platelet-activating factor in bone metabolism and disease. , 2008, Progress in lipid research.

[19]  D. Graves,et al.  The use of rodent models to investigate host-bacteria interactions related to periodontal diseases. , 2008, Journal of clinical periodontology.

[20]  T. Kawai,et al.  Interference with immune-cell-mediated bone resorption in periodontal disease. , 2007, Periodontology 2000.

[21]  K. Kirkwood,et al.  A p38 mitogen-activated protein kinase inhibitor arrests active alveolar bone loss in a rat periodontitis model. , 2007, Journal of periodontology.

[22]  P. Kostenuik,et al.  RANKL inhibition through osteoprotegerin blocks bone loss in experimental periodontitis. , 2007, Journal of periodontology.

[23]  M. Yin,et al.  Epidemiology, pathogenesis, and management of human immunodeficiency virus infection in patients with periodontal disease. , 2007, Periodontology 2000.

[24]  R. Jilka Molecular and cellular mechanisms of the anabolic effect of intermittent PTH. , 2007, Bone.

[25]  S. Gaffen,et al.  An essential role for IL-17 in preventing pathogen-initiated bone destruction: recruitment of neutrophils to inflamed bone requires IL-17 receptor-dependent signals. , 2007, Blood.

[26]  G. Garlet,et al.  Chemokines in Oral Inflammatory Diseases: Apical Periodontitis and Periodontal Disease , 2007, Journal of dental research.

[27]  J. Cirelli,et al.  Novel host response therapeutic approaches to treat periodontal diseases. , 2007, Periodontology 2000.

[28]  I. Ishikawa,et al.  The roles of cyclooxygenase-2 and prostaglandin E2 in periodontal disease. , 2007, Periodontology 2000.

[29]  Georg Schett,et al.  Dickkopf-1 is a master regulator of joint remodeling , 2007, Nature Medicine.

[30]  M. Terauchi,et al.  IFN-γ stimulates osteoclast formation and bone loss in vivo via antigen-driven T cell activation , 2007 .

[31]  G. Garlet,et al.  The dual role of p55 tumour necrosis factor‐α receptor in Actinobacillus actinomycetemcomitans‐induced experimental periodontitis: host protection and tissue destruction , 2006, Clinical and experimental immunology.

[32]  A. Togari,et al.  Cytokine-induced nitric-oxide-dependent apoptosis in mouse osteoblastic cells: involvement of p38MAP kinase. , 2006, Archives of oral biology.

[33]  Y. Izumi,et al.  B and T lymphocytes are the primary sources of RANKL in the bone resorptive lesion of periodontal disease. , 2006, The American journal of pathology.

[34]  D. Graves,et al.  Diabetes Enhances Periodontal Bone Loss through Enhanced Resorption and Diminished Bone Formation , 2006, Journal of dental research.

[35]  S. Goldring,et al.  Role of macrophages in LPS-induced osteoblast and PDL cell apoptosis. , 2006, Bone.

[36]  R. Pacifici,et al.  Estrogen Regulation of Immune Cell Bone Interactions , 2006, Annals of the New York Academy of Sciences.

[37]  D. Graves,et al.  Immunization Enhances Inflammation and Tissue Destruction in Response to Porphyromonas gingivalis , 2006, Infection and Immunity.

[38]  Y. Teng Protective and Destructive Immunity in the Periodontium: Part 2—T-cell-mediated Immunity in the Periodontium , 2006, Journal of dental research.

[39]  B. Levy,et al.  RvE1 protects from local inflammation and osteoclastmediated bone destruction in periodontitis , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[40]  D. Graves,et al.  Diabetes enhances mRNA levels of proapoptotic genes and caspase activity, which contribute to impaired healing. , 2006, Diabetes.

[41]  G. Garlet,et al.  Cytokine pattern determines the progression of experimental periodontal disease induced by Actinobacillus actinomycetemcomitans through the modulation of MMPs, RANKL, and their physiological inhibitors. , 2006, Oral microbiology and immunology.

[42]  T. Kawai,et al.  Bacterial-Responsive B Lymphocytes Induce Periodontal Bone Resorption1 , 2006, The Journal of Immunology.

[43]  Ashu Sharma,et al.  Tannerella forsythia-induced Alveolar Bone Loss in Mice Involves Leucine-rich-repeat BspA Protein , 2005, Journal of dental research.

[44]  J. Rubin,et al.  The p55 TNF receptor mediates TNF inhibition of osteoblast differentiation independently of apoptosis. , 2005, American journal of physiology. Endocrinology and metabolism.

[45]  D. Fine,et al.  The Actinobacillus actinomycetemcomitans Autotransporter Adhesin Aae Exhibits Specificity for Buccal Epithelial Cells from Humans and Old World Primates , 2005, Infection and Immunity.

[46]  Shi Wei,et al.  IL-1 mediates TNF-induced osteoclastogenesis. , 2005, The Journal of clinical investigation.

[47]  C. Clish,et al.  Reduced Inflammation and Tissue Damage in Transgenic Rabbits Overexpressing 15-Lipoxygenase and Endogenous Anti-inflammatory Lipid Mediators 1 , 2003, The Journal of Immunology.

[48]  J. Gunsolley,et al.  Periodontal host modulation with antiproteinase, anti-inflammatory, and bone-sparing agents. A systematic review. , 2003, Annals of periodontology.

[49]  B. Troen Molecular mechanisms underlying osteoclast formation and activation , 2003, Experimental Gerontology.

[50]  D. Fine,et al.  Tight-adherence genes of Actinobacillus actinomycetemcomitans are required for virulence in a rat model , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[51]  D. Graves,et al.  Inflammation and tissue loss caused by periodontal pathogens is reduced by interleukin-1 antagonists. , 2002, The Journal of infectious diseases.

[52]  G. Stein,et al.  Expression of the Osteoblast Differentiation Factor RUNX2 (Cbfa1/AML3/Pebp2αA) Is Inhibited by Tumor Necrosis Factor-α* , 2002, The Journal of Biological Chemistry.

[53]  D. Graves,et al.  Tumor Necrosis Factor Modulates Fibroblast Apoptosis, PMN Recruitment, and Osteoclast Formation in Response to P. gingivalis Infection , 2001, Journal of dental research.

[54]  G. Huang,et al.  Effect of interleukin-6 deficiency on the formation of periapical lesions after pulp exposure in mice. , 2001, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[55]  D. Graves,et al.  Soluble antagonists to interleukin-1 (IL-1) and tumor necrosis factor (TNF) inhibits loss of tissue attachment in experimental periodontitis. , 2001, Journal of clinical periodontology.

[56]  Yongwon Choi,et al.  Osteoimmunology: Bone versus immune system , 2000, Nature.

[57]  D. Roopenian,et al.  Genetic Control of Susceptibility toPorphyromonas gingivalis-Induced Alveolar Bone Loss in Mice , 2000, Infection and Immunity.

[58]  J. Penninger,et al.  Functional human T-cell immunity and osteoprotegerin ligand control alveolar bone destruction in periodontal infection. , 2000, The Journal of clinical investigation.

[59]  S. Offenbacher,et al.  Pharmacodynamic effects of ketoprofen on crevicular fluid prostanoids in adult periodontitis. , 2000, Journal of clinical periodontology.

[60]  C. Clish,et al.  Lipoxin A(4) analogues inhibit leukocyte recruitment to Porphyromonas gingivalis: a role for cyclooxygenase-2 and lipoxins in periodontal disease. , 2000, Biochemistry.

[61]  D. Graves,et al.  Interleukin-1 and tumor necrosis factor receptor signaling is not required for bacteria-induced osteoclastogenesis and bone loss but is essential for protecting the host from a mixed anaerobic infection. , 1999, The American journal of pathology.

[62]  T. Nakashima,et al.  Tumor necrosis factor-α and interleukin-1β increase the Fas-mediated apoptosis of human osteoblasts , 1999 .

[63]  D. Roopenian,et al.  CD4+ T Cells and the Proinflammatory Cytokines Gamma Interferon and Interleukin-6 Contribute to Alveolar Bone Loss in Mice , 1999, Infection and Immunity.

[64]  D. Graves,et al.  Interleukin-1 and tumor necrosis factor antagonists inhibit the progression of inflammatory cell infiltration toward alveolar bone in experimental periodontitis. , 1998, Journal of periodontology.

[65]  G. Ciliberto,et al.  IL‐6 Mediates the Effects of IL‐1 or TNF, but Not PTHrP or 1,25(OH)2D3, on Osteoclast‐like Cell Formation in Normal Human Bone Marrow Cultures , 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[66]  D. Graves,et al.  IL-1 and TNF antagonists inhibit the inflammatory response and bone loss in experimental periodontitis. , 1998, Journal of immunology.

[67]  O. Ljunggren,et al.  Inflammatory cytokines regulate proliferation of cultured human osteoblasts. , 1997, Acta orthopaedica Scandinavica.

[68]  W L Lin,et al.  Differentiation of periodontal ligament fibroblasts into osteoblasts during socket healing after tooth extraction in the rat , 1994, The Anatomical record.

[69]  D. Roopenian,et al.  Oral infection with Porphyromonas gingivalis and induced alveolar bone loss in immunocompetent and severe combined immunodeficient mice. , 1994, Archives of oral biology.

[70]  R. Page,et al.  Immunization against Porphyromonas gingivalis inhibits progression of experimental periodontitis in nonhuman primates , 1994, Infection and immunity.

[71]  R. Taichman,et al.  Effects of interleukin-1β and tumor necrosis factor-α on osteoblastic expression of osteocalcin and mineralized extracellular matrix in vitro , 1992, Inflammation.

[72]  D. Kioussis,et al.  Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis. , 1991, The EMBO journal.

[73]  M. Taubman,et al.  Effect of adoptive transfer of cloned Actinobacillus actinomycetemcomitans-specific T helper cells on periodontal disease , 1991, Infection and immunity.

[74]  F. Dewhirst,et al.  Interleukin-1 beta stimulates bone resorption and inhibits bone formation in vivo. , 1991, Lymphokine and cytokine research.

[75]  E. Canalis,et al.  Tumor necrosis factor-alpha inhibits collagen synthesis and alkaline phosphatase activity independently of its effect on deoxyribonucleic acid synthesis in osteoblast-enriched bone cell cultures. , 1988, Endocrinology.

[76]  T. Bringman,et al.  Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors , 1986, Nature.

[77]  R. Williams,et al.  Flurbiprofen: a potent inhibitor of alveolar bone resorption in beagles. , 1985, Science.

[78]  I. Takazoe,et al.  Oral implantation of Bacteroides asaccharolyticus and Eikenella corrodens in conventional hamsters , 1982, Infection and immunity.

[79]  R. Page,et al.  Current status of the host response in chronic marginal periodontitis. , 1981, Journal of periodontology.

[80]  R. Kenworthy,et al.  Studies of a periodontal tissue lesion in the rat, untreated or treated with chlorhexidine digluconate. , 1981, Journal of clinical periodontology.

[81]  D. J. Rowe,et al.  Quantitative analyses of osteoclasts, bone loss and inflammation in human periodontal disease. , 1981, Journal of periodontal research.

[82]  N. Bissada,et al.  Long term effect of systemic tetracycline administration on the severity of induced periodontitis in the rat. , 1979, Journal of periodontology.

[83]  Schroeder He,et al.  Pathogenesis of inflammatory periodontal disease. A summary of current work. , 1976 .

[84]  H. Löe,et al.  Plaque induced periodontal disease in beagle dogs. A 4-year clinical, roentgenographical and histometrical study. , 1975, Journal of periodontal research.

[85]  H. M. Bohannan,et al.  Oral debris, calculus, and periodontal disease in the beagle dog. , 1967, Periodontics.

[86]  S. Rovin,et al.  The influence of bacteria and irritation in the initiation of periodontal disease in germfree and conventional rats. , 1966, Journal of periodontal research.

[87]  H. Löe,et al.  Experimental gingivitis in man. II. A longitudinal clinical and bacteriological investigation. , 1966, Journal of periodontal research.

[88]  H. Löe,et al.  EXPERIMENTAL GINGIVITIS IN MAN. , 1965, The Journal of periodontology.

[89]  H. Jordan,et al.  PERIODONTAL LESIONS IN THE SYRIAN HAMSTER. III. FINDINGS RELATED TO AN INFECTIOUS AND TRANSMISSIBLE COMPONENT. , 1964, Archives of oral biology.

[90]  Anthony W. Gargiulo,et al.  Dimensions and Relations of the Dentogingival Junction in Humans , 1961 .

[91]  P. Keyes,et al.  Periodontal lesions in the Syrian hamster. I. A method of evaluating alveolar bone resorption. , 1955, Oral surgery, oral medicine, and oral pathology.

[92]  広 高柳,et al.  Osteoimmunology , 2013, Springer New York.

[93]  A. De Rossi,et al.  Interferon-gamma, interleukin-10, Intercellular adhesion molecule-1, and chemokine receptor 5, but not interleukin-4, attenuate the development of periapical lesions. , 2008, Journal of endodontics.

[94]  Mariana Carolina Morales Chávez,et al.  Periodontal disease associated to systemic genetic disorders. , 2007, Medicina oral, patologia oral y cirugia bucal.

[95]  M. Terauchi,et al.  IFN-gamma stimulates osteoclast formation and bone loss in vivo via antigen-driven T cell activation. , 2007, The Journal of clinical investigation.

[96]  M. Somerman,et al.  Advances in defining regulators of cementum development and periodontal regeneration. , 2007, Current topics in developmental biology.

[97]  G. Stein,et al.  Expression of the osteoblast differentiation factor RUNX2 (Cbfa1/AML3/Pebp2alpha A) is inhibited by tumor necrosis factor-alpha. , 2002, The Journal of biological chemistry.

[98]  W. Ries,et al.  Characterization of interferon gamma receptors on osteoclasts: Effect of interferon gamma on osteoclastic superoxide generation , 2002, Journal of cellular biochemistry.

[99]  M. Nanes,et al.  Inhibition of osteoblast differentiation by tumor necrosis factor-alpha. , 2000, Endocrinology.

[100]  T. Nakashima,et al.  Tumor necrosis factor-alpha and interleukin-1beta increase the Fas-mediated apoptosis of human osteoblasts. , 1999, The Journal of laboratory and clinical medicine.

[101]  D. Graves,et al.  Fibroblasts, mononuclear phagocytes, and endothelial cells express monocyte chemoattractant protein-1 (MCP-1) in inflamed human gingiva. , 1995, Journal of periodontology.

[102]  R. Taichman,et al.  Effects of interleukin-1 beta and tumor necrosis factor-alpha on osteoblastic expression of osteocalcin and mineralized extracellular matrix in vitro. , 1992, Inflammation.

[103]  F. Dewhirst,et al.  Interleukin-1 beta is a potent inhibitor of bone formation in vitro. , 1987, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[104]  A. Parfitt The coupling of bone formation to bone resorption: a critical analysis of the concept and of its relevance to the pathogenesis of osteoporosis. , 1982, Metabolic bone disease & related research.

[105]  J. Lindhe,et al.  Conditions and pathological features of rapidly destructive, experimental periodontitis in dogs. , 1980, Journal of periodontology.

[106]  R. Page,et al.  Pathogenesis of inflammatory periodontal disease. A summary of current work. , 1976, Laboratory investigation; a journal of technical methods and pathology.

[107]  Rongkun Liu,et al.  Tumor Necrosis Factor- (cid:1) Mediates Diabetes-Enhanced Apoptosis of Matrix-Producing Cells and Impairs Diabetic Healing , 2006 .